Work

Mo1763 TARGETING MICROBIOTA-GUT-BRAIN AXIS IN ALZHEIMER’S DISEASE: EFFECTS OF A NOVEL PROBIOTIC FORMULATION ACTING ON EPITHELIAL/VASCULAR BARRIER AND PERIVASCULAR INFLAMMATION